RAYMOND G. GOODWIN

Person

SEATTLE, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of use of the TACI/TACI-L interaction
- Patent number 8,133,976
- Issue date Mar 13, 2012
- Immunex Corporation
- Raymond G. Goodwin
- G01 - MEASURING TESTING
Information Patent Grant
DNA encoding a soluble fragment of TRAIL polypeptide
- Patent number 7,972,812
- Issue date Jul 5, 2011
- Immunex Corporation
- Steven R. Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of TRAIL polypeptides to induce apoptosis
- Patent number 7,736,637
- Issue date Jun 15, 2010
- Immunex Corporation
- Steven R. Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glycoproteins which bind to TNF
- Patent number 7,459,528
- Issue date Dec 2, 2008
- Immunex Corporation
- Craig A. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Receptor that causes cell death and recombinant production thereof
- Patent number 7,416,877
- Issue date Aug 26, 2008
- Immunex Corporation
- Mariapia A. Degli-Esposti Rankin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD30 ligand
- Patent number 7,232,660
- Issue date Jun 19, 2007
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-1BB polypeptides and DNA encoding 4-1BB polypeptides
- Patent number 7,211,259
- Issue date May 1, 2007
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to human 4-1BB
- Patent number 7,138,500
- Issue date Nov 21, 2006
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies which specifically bind to TNF-R
- Patent number 7,057,022
- Issue date Jun 6, 2006
- Immunex Corporation
- Craig A. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Viral proteins capable of binding LAR
- Patent number 6,852,486
- Issue date Feb 8, 2005
- Immunex Corp.
- Craig A. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD30 ligand
- Patent number 6,667,039
- Issue date Dec 23, 2003
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for suppressing inflammatory responses by administering TNFR
- Patent number 6,572,852
- Issue date Jun 3, 2003
- Immunex Corporation
- Craig A. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against trail
- Patent number 6,521,228
- Issue date Feb 18, 2003
- Immunex Corporation
- Steven R. Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cytokine designated 4-1BB ligand antibodies and human receptor that...
- Patent number 6,355,779
- Issue date Mar 12, 2002
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine that induces apoptosis
- Patent number 6,284,236
- Issue date Sep 4, 2001
- Immunex Corporation
- Steven R. Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tumor necrosis factor-α and -β receptors
- Patent number 6,224,867
- Issue date May 1, 2001
- Immunex Corporation
- Craig A. Smith
Information Patent Grant
Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)
- Patent number 6,201,105
- Issue date Mar 13, 2001
- Craig A. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of interleukin-7 to stimulate proliferation of hematopoietic ce...
- Patent number 6,156,301
- Issue date Dec 5, 2000
- Sanofi-Synthelabo
- Anthony E. Namen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD30 ligand oligomers and polypeptides
- Patent number 6,143,869
- Issue date Nov 7, 2000
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors
- Patent number RE36755
- Issue date Jun 27, 2000
- Immunex Corporation
- Craig A. Smith
- 435 - Chemistry: molecular biology and microbiology
Information Patent Grant
Use of interleukin-7 to stimulate proliferation of hematopoietic ce...
- Patent number 5,965,122
- Issue date Oct 12, 1999
- Sanofi
- Anthony E. Namen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purified p75 (type II) tumor necrosis factor receptor polypeptides
- Patent number 5,945,397
- Issue date Aug 31, 1999
- Immunex Corporation
- Craig A. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine which is a ligand for OX40
- Patent number 5,783,665
- Issue date Jul 21, 1998
- Immunex Corporation
- Peter R. Baum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
DNA encoding a cytokine that induces apoptosis
- Patent number 5,763,223
- Issue date Jun 9, 1998
- Immunex Corporation
- Steven R. Wiley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD30 ligand conjugates
- Patent number 5,753,203
- Issue date May 19, 1998
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that are immunoreactive with interleukin-7
- Patent number 5,714,585
- Issue date Feb 3, 1998
- Sterling Winthrop, Inc.
- Anthony E. Namen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors
- Patent number 5,712,155
- Issue date Jan 27, 1998
- Immunex Corporation
- Craig A. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of interleukin-7 to stimulate proliferation of hematopoietic ce...
- Patent number 5,705,149
- Issue date Jan 6, 1998
- Sterling Winthrop Inc.
- Anthony E. Namen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against CD30 ligand
- Patent number 5,677,430
- Issue date Oct 14, 1997
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine designated 4-IBB ligand
- Patent number 5,674,704
- Issue date Oct 7, 1997
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Use of Trail Polypeptides to Treat Cancer
- Publication number 20100323399
- Publication date Dec 23, 2010
- IMMUNEX CORPORATION
- Steven R. Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USE OF THE TACI/TACI-L INTERACTION
- Publication number 20100196404
- Publication date Aug 5, 2010
- Immunex Corporation
- Raymond G. Goodwin
- G01 - MEASURING TESTING
Information Patent Application
Purified TNFR preparations
- Publication number 20090270592
- Publication date Oct 29, 2009
- Immunex Corporation
- Craig A. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD30 Ligand
- Publication number 20090264349
- Publication date Oct 22, 2009
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of TRAIL Polypeptides to Treat Cancer
- Publication number 20090118186
- Publication date May 7, 2009
- IMMUNEX CORPORATION
- Steven R. Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of use of the TACI/TACI-L interaction
- Publication number 20090081700
- Publication date Mar 26, 2009
- Immunex Corporation
- Raymond G. Goodwin
- G01 - MEASURING TESTING
Information Patent Application
NK cell activation inducing ligand (NAIL) DNA and polypeptides, and...
- Publication number 20080081043
- Publication date Apr 3, 2008
- Marek Z. Kubin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel receptor that causes cell death
- Publication number 20070298460
- Publication date Dec 27, 2007
- Immunex Corporation
- Mariapia A. Degli-Esposti Rankin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cytokine designated 4-1BB ligand and human receptor that binds thereto
- Publication number 20060127985
- Publication date Jun 15, 2006
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cytokine designated 4-1BB ligand and human receptor that binds thereto
- Publication number 20060110802
- Publication date May 25, 2006
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Glycoproteins which bind to TNF
- Publication number 20060067934
- Publication date Mar 30, 2006
- Immunex Corporation
- Craig A. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Viral proteins capable of binding LAR
- Publication number 20050176640
- Publication date Aug 11, 2005
- Immunex Corporation
- Craig A. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of using a cytokine that induces apoptosis
- Publication number 20050158823
- Publication date Jul 21, 2005
- Immunex Corporation
- Steven R. Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD 30 ligand
- Publication number 20040241758
- Publication date Dec 2, 2004
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel receptor that causes cell death
- Publication number 20040180826
- Publication date Sep 16, 2004
- Immunex Corporation
- Mariapia A. Degli-Esposti Rankin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cytokine that induces apoptosis
- Publication number 20040052788
- Publication date Mar 18, 2004
- Immunex Corporation
- Steven R. Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies which specifically bind to TNF-R
- Publication number 20030165459
- Publication date Sep 4, 2003
- Immunex Corporation
- Craig A. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of use of the TACI/TACI-L interaction
- Publication number 20030165986
- Publication date Sep 4, 2003
- Immunex Corporation
- Raymond G. Goodwin
- G01 - MEASURING TESTING
Information Patent Application
Viral proteins capable of binding LAR
- Publication number 20030049609
- Publication date Mar 13, 2003
- Craig A. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF USE OF THE TACI/TACI-L INTERACTION
- Publication number 20030022233
- Publication date Jan 30, 2003
- RAYMOND G. GOODWIN
- G01 - MEASURING TESTING
Information Patent Application
Tumor Necrosis factor-alpha and -beta receptors
- Publication number 20020006391
- Publication date Jan 17, 2002
- Graig A. Smith
- C07 - ORGANIC CHEMISTRY

RAYMOND G. GOODWIN

Person

Patents Grantslast 30 patents

Methods of use of the TACI/TACI-L interaction

DNA encoding a soluble fragment of TRAIL polypeptide

Use of TRAIL polypeptides to induce apoptosis

Glycoproteins which bind to TNF

Receptor that causes cell death and recombinant production thereof

CD30 ligand

4-1BB polypeptides and DNA encoding 4-1BB polypeptides

Antibodies to human 4-1BB

Antibodies which specifically bind to TNF-R

Viral proteins capable of binding LAR

CD30 ligand

Method for suppressing inflammatory responses by administering TNFR

Antibodies directed against trail

Cytokine designated 4-1BB ligand antibodies and human receptor that...

Cytokine that induces apoptosis

Tumor necrosis factor-&#x03B1; and -&#x03B2; receptors

Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)

Use of interleukin-7 to stimulate proliferation of hematopoietic ce...

CD30 ligand oligomers and polypeptides

DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors

Use of interleukin-7 to stimulate proliferation of hematopoietic ce...

Purified p75 (type II) tumor necrosis factor receptor polypeptides

Cytokine which is a ligand for OX40

DNA encoding a cytokine that induces apoptosis

CD30 ligand conjugates

Antibodies that are immunoreactive with interleukin-7

DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors

Use of interleukin-7 to stimulate proliferation of hematopoietic ce...

Antibodies directed against CD30 ligand

Cytokine designated 4-IBB ligand

Patents Applicationslast 30 patents

Use of Trail Polypeptides to Treat Cancer

METHODS OF USE OF THE TACI/TACI-L INTERACTION

Purified TNFR preparations

CD30 Ligand

Use of TRAIL Polypeptides to Treat Cancer

Methods of use of the TACI/TACI-L interaction

NK cell activation inducing ligand (NAIL) DNA and polypeptides, and...

Novel receptor that causes cell death

Cytokine designated 4-1BB ligand and human receptor that binds thereto

Cytokine designated 4-1BB ligand and human receptor that binds thereto

Glycoproteins which bind to TNF

Viral proteins capable of binding LAR

Method of using a cytokine that induces apoptosis

CD 30 ligand

Novel receptor that causes cell death

Cytokine that induces apoptosis

Antibodies which specifically bind to TNF-R

Methods of use of the TACI/TACI-L interaction

Viral proteins capable of binding LAR

METHODS OF USE OF THE TACI/TACI-L INTERACTION

Tumor Necrosis factor-alpha and -beta receptors

Tumor necrosis factor-α and -β receptors